Your browser doesn't support javascript.
loading
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer.
Gupta, Nitasha; Huang, Tzu-Ting; Nair, Jayakumar R; An, Daniel; Zurcher, Grant; Lampert, Erika J; McCoy, Ann; Cimino-Mathews, Ashley; Swisher, Elizabeth M; Radke, Marc R; Lockwood, Christina M; Reichel, Jonathan B; Chiang, Chih-Yuan; Wilson, Kelli M; Cheng, Ken Chih-Chien; Nousome, Darryl; Lee, Jung-Min.
Afiliación
  • Gupta N; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Huang TT; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Nair JR; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • An D; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Zurcher G; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Lampert EJ; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • McCoy A; Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Cimino-Mathews A; Women's Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Swisher EM; Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Radke MR; Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, WA 98195, USA.
  • Lockwood CM; Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, WA 98195, USA.
  • Reichel JB; Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, WA 98195, USA.
  • Chiang CY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Wilson KM; Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, WA 98195, USA.
  • Cheng KC; National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Rockville, MD 20892, USA.
  • Nousome D; National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Rockville, MD 20892, USA.
  • Lee JM; National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Rockville, MD 20892, USA.
Sci Transl Med ; 15(701): eadd7872, 2023 06 21.
Article en En | MEDLINE | ID: mdl-37343085

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos